Global Cardiovascular and Soft Tissue Repair Patches Market Report and Forecast 2023-2031

Global Cardiovascular and Soft Tissue Repair Patches Market Report and Forecast 2023-2031


Global Cardiovascular and Soft Tissue Repair Patches Market Outlook:


The global cardiovascular and soft tissue repair Patches market value was USD 4.2 billion in 2022, driven by the increasing prevalence of cardiovascular diseases and the rising incidence of soft tissue injuries across the globe. The market size is anticipated to grow at a CAGR of 8.2% during the forecast period of 2023-2031 to achieve a value of USD 8.6 billion by 2031.

Introduction

Cardiovascular and soft tissue repair patches are medical devices used in surgical procedures to repair damaged or weakened tissues in the cardiovascular system and soft tissues of the body. These patches are typically made from biocompatible materials such as synthetic polymers or biologic materials like extracellular matrix (ECM) derived from human or animal sources. They provide structural support, promote tissue regeneration, and aid in the healing process.

The global market for cardiovascular and soft tissue repair patches is driven by several key factors. Firstly, the increasing prevalence of cardiovascular diseases, such as coronary artery disease and heart valve disorders, is leading to a growing demand for surgical interventions and repair procedures. Additionally, the rising incidence of soft tissue injuries and defects, often caused by trauma, tumors, or congenital anomalies, is fueling the need for effective repair solutions.

Key Trends in the Cardiovascular and Soft Tissue Repair Patches Market


Some key trends involved in the cardiovascular and soft tissue repair patches market are as follows:

One of the key trends in this market is the development of bioactive patches that incorporate growth factors, cytokines, or other biologically active substances to enhance tissue regeneration and promote faster healing. These bioactive patches have shown promising results in improving patient outcomes and reducing the risk of complications.

Another trend is the use of tissue engineering and regenerative medicine techniques to create advanced patches that closely mimic the native tissues in terms of structure, function, and mechanical properties. These tissue-engineered patches have the potential to provide better long-term outcomes and reduce the risk of graft failure or complications.

Cardiovascular and Soft Tissue Repair Patches Market Segmentations


Market Breakup by Type

EPTFE
Biomaterial
Tissue Engineered Material
Market Breakup by Application

Cardiac Repair
Vascular Repair
Pericardial Repair
Dural Repair
Soft Tissue Repair
Market Breakup by End User

Hospitals
Clinics
Other end-Users
Market Breakup by Region

North America
United States of America
Canada
Europe
United Kingdom
Germany
France
Italy
Others
Asia Pacific
China
Japan
India
ASEAN
Australia
Others
Latin America
Brazil
Argentina
Mexico
Others
Middle East and Africa
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others

Cardiovascular and Soft Tissue Repair Patches Market Scenario


The cardiovascular and soft tissue repair patches market is a growing sector within the healthcare industry that focuses on providing effective solutions for repairing damaged tissues in the cardiovascular system and soft tissues of the body. These patches are designed to provide structural support, promote tissue regeneration, and facilitate the healing process.

The market is primarily driven by the increasing prevalence of cardiovascular diseases and the rising incidence of soft tissue injuries. Cardiovascular diseases, such as coronary artery disease and heart valve disorders, are leading causes of morbidity and mortality worldwide. As a result, there is a growing demand for surgical interventions and repair procedures, driving the need for cardiovascular repair patches.

Soft tissue injuries, whether due to trauma, tumors, or congenital anomalies, also require effective repair solutions. Soft tissue repair patches are used in various procedures, including hernia repair, tendon repair, and breast reconstruction, among others. The rising awareness about the importance of early intervention and effective treatment options has contributed to the growth of this market.

In conclusion, the cardiovascular and soft tissue repair patches market is driven by the growing prevalence of cardiovascular diseases and soft tissue injuries, advancements in patch materials and technology, and the increasing adoption of minimally invasive and regenerative medicine approaches. As the demand for effective repair solutions continues to rise, the market is expected to witness further growth and innovation in the coming years.

Cardiovascular and Soft Tissue Repair Patches Market: Competitor Landscape


The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

CryoLife, Inc
Edwards Lifesciences Corporation (U.S)
Bard Peripheral Vascular
Baxter
Anteris
Neovasc Inc.
Southernlight Biomaterials
Medtronic
GETINGE AB
W. L. Gore & Associates, Inc.
Abbot
LeMaitre Vascular Inc.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Cardiovascular and Soft Tissue Repair Patches Market Overview
3.1 Cardiovascular and Soft Tissue Repair Patches Market Historical Value (2016-2022)
3.2 Cardiovascular and Soft Tissue Repair Patches Market Forecast Value (2023-2031)
4 Cardiovascular and Soft Tissue Repair Patches Market Landscape
4.1 Cardiovascular and Soft Tissue Repair Patches: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Cardiovascular and Soft Tissue Repair Patches: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End user
5 Cardiovascular and Soft Tissue Repair Patches Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Cardiovascular and Soft Tissue Repair Patches Market Segmentation
6.1 Cardiovascular and Soft Tissue Repair Patches Market by Type
6.1.1 Market Overview
6.1.2 EPTFE
6.1.3 Biomaterial
6.1.4 Tissue Engineered Material
6.2 Cardiovascular and Soft Tissue Repair Patches Market by Application
6.2.1 Cardiac Repair
6.2.2 Vascular Repair
6.2.3 Pericardial Repair
6.2.4 Dural Repair
6.2.5 Soft Tissue Repair
6.3 Cardiovascular and Soft Tissue Repair Patches Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Other end-Users
6.4 Cardiovascular and Soft Tissue Repair Patches Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cardiovascular and Soft Tissue Repair Patches
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cardiovascular and Soft Tissue Repair Patches
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cardiovascular and Soft Tissue Repair Patches
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cardiovascular and Soft Tissue Repair Patches
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cardiovascular and Soft Tissue Repair Patches
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 CryoLife, Inc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Edwards Lifesciences Corporation (U.S)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bard Peripheral Vascular
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Baxter
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Anteris
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Neovasc Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Southernlight Biomaterials
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medtronic plc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 GETINGE AB
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 W. L. Gore & Associates, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Abbott
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 LeMaitre Vascular Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Cardiovascular and Soft Tissue Repair Patches - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings